8-KOther Events

REGENERON PHARMACEUTICALS, INC. 8-K Report (Oct 31, 2003)

Filed October 31, 2003For Securities:REGN

Summary

Regeneron Pharmaceuticals, Inc. filed an 8-K on October 31, 2003, to report a financial results press release dated October 30, 2003. This filing primarily serves to correct a minor error present in a prior press release issued on September 29, 2003. Investors should note that this 8-K itself does not contain new financial data but rather an amendment/clarification to previously released information concerning the fiscal quarter ended September 30, 2003. While the specific details of the financial results and the nature of the error are not detailed within this 8-K document itself (as they are in the attached press release, Exhibit 99(a)), the filing signifies the company's commitment to accurate financial reporting and regulatory disclosure. Investors interested in the updated financial performance for the quarter ending September 30, 2003, should refer to the attached press release.

Key Highlights

  • 1Regeneron Pharmaceuticals, Inc. filed an 8-K on October 31, 2003.
  • 2The filing's primary purpose is to attach a press release dated October 30, 2003.
  • 3This press release provides updated financial results for the fiscal quarter ended September 30, 2003.
  • 4The October 30, 2003 press release corrects a minor error from a previous release on September 29, 2003.
  • 5The 8-K itself serves as a disclosure mechanism for the corrected financial information.
  • 6The filing is in accordance with Regulation FD and Disclosure of Operations and Financial Condition.
  • 7Investors should consult the referenced press release (Exhibit 99(a)) for the specific financial details and the nature of the correction.

Frequently Asked Questions

The main purpose of this 8-K filing is to disclose a press release dated October 30, 2003, which provides updated financial results for the fiscal quarter ended September 30, 2003. This press release corrects a minor error found in a prior press release issued on September 29, 2003.

No, this 8-K filing does not contain the detailed financial results within its text. Instead, it serves to attach a press release (Exhibit 99(a)) that contains this information. Investors need to refer to the attached press release for the specific financial data and the correction made.

The filing mentions that a 'minor error' in a previous press release from September 29, 2003, was corrected. The specific nature of this error and the corrected figures are detailed in the press release dated October 30, 2003, which is attached as Exhibit 99(a) to this 8-K.

No, the filing explicitly states that the information included in this Current Report on Form 8-K shall not be deemed 'filed' for purposes of the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing. This typically means it's furnished information rather than formally filed, though it still serves a disclosure purpose.